Xiao-Jun Lin
Overview
Explore the profile of Xiao-Jun Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
1809
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
31.
Wan L, Liu T, Lin X, Min Q, Chen J
Molecules
. 2013 Jul;
18(7):8518-23.
PMID: 23873389
Two rare new chiratane-type triterpenoids, kouitchenoids A and B (1, 2), together with oleanolic acid (3) and ursolic acid (4), were isolated from ethanol extract of Swertia kouitchensis. The new...
32.
Peng Z, Zhang Y, Chen M, Xu L, Liang H, Lin X, et al.
J Clin Oncol
. 2012 Dec;
31(4):426-32.
PMID: 23269991
Purpose: To compare radiofrequency ablation (RFA) with or without transcatheter arterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC). Patients And Methods: A randomized controlled trial was conducted on...
33.
Shi M, Lu L, Fang W, Guo R, Chen M, Li Y, et al.
J Natl Cancer Inst
. 2012 Nov;
105(1):59-68.
PMID: 23150720
Background: The aim of our study was to compare the efficacy and safety of: 1) transarterial chemolipiodolization with gelatin sponge embolization vs chemolipiodolization without embolization, and 2) chemolipiodolization with triple...
34.
Wang Q, Cui B, Weng J, Wu Q, Qiu J, Lin X
J Gastrointest Surg
. 2012 Jul;
16(9):1715-26.
PMID: 22767081
Background: Primary sarcomatoid carcinoma (SC) and carcinosarcoma (CS) of the liver are rare tumors. Patients And Methods: From November 1999 to June 2011, clinicopathological features and outcome of 10 SC...
35.
Cui B, Liu S, Li S, Wang J, Wang Q, Li S, et al.
Int J Mol Sci
. 2012 Jul;
13(5):5571-5583.
PMID: 22754316
The purpose of this study was to evaluate the antioxidant nature of tea polyphenol on S180 cells induced liver cancer in mice. In the present study, hepatocellular carcinoma was induced...
36.
Cai X, Luo M, Lin X, Xu Y, Tang C, Ye J, et al.
Zhonghua Yi Xue Za Zhi
. 2012 Apr;
92(7):460-3.
PMID: 22490966
Objective: To explore the expression and significance of Th17 and Treg cells in peripheral blood of patients with systemic lupus erythematosus (SLE). Methods: Thirty active SLE patients (including 17 SLE...
37.
Peng Z, Guo R, Zhang Y, Lin X, Chen M, Lau W
Cancer
. 2012 Feb;
118(19):4725-36.
PMID: 22359112
Background: The long-term survival outcomes of hepatic resection (HR) compared with transcatheter arterial chemoembolization (TACE) for resectable hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) are unclear. Materials And...
38.
Peng Z, Lin X, Zhang Y, Liang H, Guo R, Shi M, et al.
Radiology
. 2012 Feb;
262(3):1022-33.
PMID: 22357902
Purpose: To compare retrospectively the effects of percutaneous radiofrequency (RF) ablation with those of hepatic resection in the treatment of hepatocellular carcinoma (HCC) measuring 2 cm or smaller. Materials And...
39.
Peng Z, Zhang Y, Liang H, Lin X, Guo R, Chen M
Radiology
. 2011 Dec;
262(2):689-700.
PMID: 22157201
Purpose: To compare prospectively the effects of radiofrequency (RF) ablation after transcatheter arterial chemoembolization (TACE) with those of RF ablation alone in the treatment of recurrent hepatocellular carcinoma (HCC). Materials...
40.
Lin X, Luo M, Cai X
Zhonghua Yi Xue Za Zhi
. 2011 May;
91(9):586-90.
PMID: 21600126
Objective: To explore the role of fas apoptosis signal transduction pathway in the abnormal apoptosis of Foxp3+CD4+CD25+ Treg in patients with systemic lupus erythematosus (SLE). Methods: Twenty-five active SLE patients,...